267 related articles for article (PubMed ID: 27453425)
1. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
Bègue I; Kaiser S; Kirschner M
Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
[TBL] [Abstract][Full Text] [Related]
3. [The clinic of apathy in schizophrenia: a critical review of the issue].
Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
[TBL] [Abstract][Full Text] [Related]
4. Recognizing primary vs secondary negative symptoms and apathy vs expression domains.
Kirkpatrick B
J Clin Psychiatry; 2014 Apr; 75(4):e09. PubMed ID: 24813410
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
[TBL] [Abstract][Full Text] [Related]
6. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
[TBL] [Abstract][Full Text] [Related]
7. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
Kirkpatrick B
J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
[TBL] [Abstract][Full Text] [Related]
8. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
Guessoum SB; Le Strat Y; Dubertret C; Mallet J
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
[TBL] [Abstract][Full Text] [Related]
9. Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.
Ahmed AO; Kirkpatrick B; Granholm E; Rowland LM; Barker PB; Gold JM; Buchanan RW; Outram T; Bernardo M; Paz García-Portilla M; Mane A; Fernandez-Egea E; Strauss GP
Schizophr Bull; 2022 May; 48(3):620-630. PubMed ID: 35020936
[TBL] [Abstract][Full Text] [Related]
10. [Negative symptoms in schizophrenia - overview and practical implications].
Klaus F; Dorsaz O; Kaiser S
Rev Med Suisse; 2018 Sep; 14(619):1660-1664. PubMed ID: 30230774
[TBL] [Abstract][Full Text] [Related]
11. [History and current state of the problem of negative disorders (research of nosological period)].
Smulevich AB; Lobanova VM; Voronova EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):122-130. PubMed ID: 33728861
[TBL] [Abstract][Full Text] [Related]
12. [Negative Symptoms in Schizophrenia - an Overview].
Klaus F; Kaiser S; Kirschner M
Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
[TBL] [Abstract][Full Text] [Related]
13. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
[TBL] [Abstract][Full Text] [Related]
14. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
Hartmann-Riemer MN; Hager OM; Kirschner M; Bischof M; Kluge A; Seifritz E; Kaiser S
Schizophr Res; 2015 Dec; 169(1-3):427-432. PubMed ID: 26526750
[TBL] [Abstract][Full Text] [Related]
15. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
[TBL] [Abstract][Full Text] [Related]
16. Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Esfahlani FZ; Galderisi S; Mucci A; Rossi A; Bucci P; Rocca P; Maj M; Kirkpatrick B; Ruiz I; Sayama H
Schizophr Bull; 2019 Sep; 45(5):1033-1041. PubMed ID: 30256991
[TBL] [Abstract][Full Text] [Related]
17. Measuring motivation in people with schizophrenia.
Fervaha G; Foussias G; Takeuchi H; Agid O; Remington G
Schizophr Res; 2015 Dec; 169(1-3):423-426. PubMed ID: 26391283
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
[TBL] [Abstract][Full Text] [Related]
19. [Negative symptoms in schizophrenia: psychotherapeutic approaches].
Azorin JM; Adida M; Belzeaux R; Pringuey D; Micoulaud Franchi JA; Simon N; Cermolacce M; Kaladjian A; Fakra E
Encephale; 2015 Dec; 41(6 Suppl 1):6S57-60. PubMed ID: 26776394
[TBL] [Abstract][Full Text] [Related]
20. Executive dysfunctions differentially predict amotivation in first-episode schizophrenia-spectrum disorder: a prospective 1-year follow-up study.
Chang WC; Liu JTT; Hui CLM; Chan SKW; Lee EHM; Suen YN; Chen EYH
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):887-896. PubMed ID: 29934845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
